| MicroRNAs impair MET-mediated invasive growth C Migliore, A Petrelli, E Ghiso, S Corso, L Capparuccia, A Eramo, ... Cancer research 68 (24), 10128-10136, 2008 | 215 | 2008 |
| Silencing the MET oncogene leads to regression of experimental tumors and metastases S Corso, C Migliore, E Ghiso, G De Rosa, PM Comoglio, S Giordano Oncogene 27 (5), 684-693, 2008 | 192 | 2008 |
| HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells G Comito, M Calvani, E Giannoni, F Bianchini, L Calorini, E Torre, ... Free Radical Biology and Medicine 51 (4), 893-904, 2011 | 180 | 2011 |
| MiR-1 Downregulation Cooperates with MACC1 in Promoting MET Overexpression in Human Colon Cancer C Migliore, V Martin, VP Leoni, A Restivo, L Atzori, A Petrelli, C Isella, ... Clinical Cancer Research 18 (3), 737-747, 2012 | 158 | 2012 |
| Molecular cancer therapy: can our expectation be MET? C Migliore, S Giordano European Journal of Cancer 44 (5), 641-651, 2008 | 152 | 2008 |
| MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular … A Petrelli, A Perra, D Cora, P Sulas, S Menegon, C Manca, C Migliore, ... Hepatology 59 (1), 228-241, 2014 | 124 | 2014 |
| Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition S Corso, E Ghiso, V Cepero, JR Sierra, C Migliore, A Bertotti, L Trusolino, ... Molecular cancer 9, 1-13, 2010 | 113 | 2010 |
| YAP-dependent AXL overexpression mediates resistance to EGFR inhibitors in NSCLC E Ghiso, C Migliore, V Ciciriello, E Morando, A Petrelli, S Corso, ... Neoplasia 19 (12), 1012-1021, 2017 | 107 | 2017 |
| Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression A Petrelli, A Perra, K Schernhuber, M Cargnelutti, A Salvi, C Migliore, ... Oncogene 31 (42), 4517-4526, 2012 | 89 | 2012 |
| A comprehensive PDX gastric cancer collection captures cancer cell–intrinsic transcriptional MSI traits S Corso, C Isella, SE Bellomo, M Apicella, S Durando, C Migliore, ... Cancer research 79 (22), 5884-5896, 2019 | 74 | 2019 |
| Cancer-associated fibroblasts promote aggressive gastric cancer phenotypes via heat shock factor 1–mediated secretion of extracellular vesicles N Grunberg, M Pevsner-Fischer, T Goshen-Lago, J Diment, Y Stein, ... Cancer research 81 (7), 1639-1653, 2021 | 71 | 2021 |
| Human ASH‐1 promotes neuroendocrine differentiation in androgen deprivation conditions and interferes with androgen responsiveness in prostate cancer cells I Rapa, M Volante, C Migliore, A Farsetti, A Berruti, G Vittorio Scagliotti, ... The Prostate 73 (11), 1241-1249, 2013 | 41 | 2013 |
| Resistance to targeted therapies: a role for microRNAs? C Migliore, S Giordano Trends in molecular medicine 19 (10), 633-642, 2013 | 40 | 2013 |
| miR‐205 mediates adaptive resistance to MET inhibition via ERRFI 1 targeting and raised EGFR signaling C Migliore, E Morando, E Ghiso, S Anastasi, VP Leoni, M Apicella, ... EMBO molecular medicine 10 (9), e8746, 2018 | 32 | 2018 |
| Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort M Apicella, C Migliore, T Capelôa, S Menegon, M Cargnelutti, M Degiuli, ... Oncogene 36 (9), 1200-1210, 2017 | 29 | 2017 |
| RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization A Germano, I Rapa, M Volante, S De Francia, C Migliore, A Berruti, ... Molecular and Cellular Endocrinology 401, 105-110, 2015 | 26 | 2015 |
| Rituximab treatment prevents lymphoma onset in gastric cancer patient-derived xenografts S Corso, M Cargnelutti, S Durando, S Menegon, M Apicella, C Migliore, ... Neoplasia 20 (5), 443-455, 2018 | 20 | 2018 |
| MiRNAs as new master players C Migliore, S Giordano Cell Cycle 8 (14), 2185-2186, 2009 | 19 | 2009 |
| Potential role of two novel agonists of thyroid hormone receptor‐β on liver regeneration A Perra, MA Kowalik, L Cabras, M Runfola, S Sestito, C Migliore, ... Cell Proliferation 53 (5), e12808, 2020 | 17 | 2020 |
| HER2 Copy Number and Resistance Mechanisms in Patients with HER2-positive Advanced Gastric Cancer Receiving Initial Trastuzumab-based Therapy in … F Pietrantonio, P Manca, SE Bellomo, S Corso, A Raimondi, E Berrino, ... Clinical Cancer Research 29 (3), 571-580, 2023 | 13 | 2023 |
